Browsing Category

Top Industry News

7526 posts

FDA Launches Pre-Check Program to Boost US-Based Drug Mfg 
By

By
The US Food and Drug Administration (FDA) has announced FDA PreCheck, a new program the agency says is designed to strengthen the domestic pharmaceutical supply chain by increasing regulatory predictability…

Bayer, Kumquat Biosciences in $1.3-Bn Cancer Drug Pact 
By

By
Bayer and Kumquat Biosciences, a San Diego, California-based clinical-stage biotech company, have entered into an exclusive global license and collaboration to develop and commercialize a cancer drug by Kumquat, a…

Supplier News: Pace Life Sciences, Sartorius, ProBio, Sanner & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Pace Life Sciences, Sartorius, Acrinova, ProBio, Sanner, Nanotein Technologies.   Biologics Manufacturing * ProBio Launches AAV Mfg Services * Sartorius, Nanotein Technologies Partner for Cell…

Moderna To Cut Workforce by 10% 
By

By
Moderna, a Cambridge, Massachusetts-based vaccine manufacturer and specialist in mRNA technology-based products, has announced an organizational restructuring that will reduce its global workforce by approximately 10%. The company anticipates a…

Vaccine Maker Bavarian Nordic Awaits $3-Bn Purchase Offer by PE Firms
By

By
Bavarian Nordic, a Hellerup, Denmark-based vaccine company, has entered into an announcement agreement for an all-cash recommended purchase offer of approximately DKK 19 billion ($2.91 billion) with a private equity…

GSK, Hengrui Pharma in $12.5-Bn Multi-Drug Pact 
By

By
GSK has entered into agreements with Hengrui Pharma, a Lianyungang, China-based bio/pharmaceutical company, to develop up to 12 medicines across several therapeutic areas (respiratory, immunology & inflammation, and oncology) in…

Supplier News: Esteve CDMO, Axplora, Bora, Garonit Pharmaceuticals & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Garonit Pharmaceuticals, Axplora, Bora Pharmaceuticals, Esteve CDMO, Asahi Kasei, and Solvias USA.   Chemicals/Chemical API Manufacturing * Ofichem Acquires Early-Phase Drug-Substance Site from Meribel…

M&A News: Sanofi, Aurobindo, Lilly & More 
By

By
The latest news on mergers and acquisitions featuring Sanofi/Vigil Neuroscience, Aurobindo/Lannett and Eli Lilly and Company/Verve Therapeutics. Highlights below.  * Sanofi Acquires Vigil Neuroscience for $470 M * Aurobindo To Acquire…

Merck & Co. Launches $3-Bn Restructuring Plan
By

By
Merck & Co. has launched a new multiyear optimization to generate an expected $3.0 billion in annual cost savings from productivity actions, which the company says will be fully reinvested…

Novo Nordisk Names New CEO; Makes Other Leadership Changes
By

By
Novo Nordisk has appointed Maziar Mike Doustdar, currently Novo Nordisk’s Executive Vice President of International Operations, as President and Chief Executive Officer, effective August 7, 2025. He succeeds Lars Fruergaard Jørgensen,…